Intragastric Balloons Market By Treatment type 2022 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Intragastric Balloons Market
Intragastric Balloons Market: By Type (Fluid-Filled, Air-Filled) & By Region (Europe, North America, Asia-Pacific, RoW)-Forecast (2017-2021)
Report Code : CMR 0599
Published: 03 August, 2017  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
An intragastric balloon is an innovative weight-loss procedure, where a saline-filled silicone balloon is placed in the stomach of a patient, which helps the patient lose weight by limiting how much they can eat. A soft, round, inflatable balloon made of medical-grade silicon is placed inside the stomach through a gastro-scope that enters through the mouth. Once inserted into the stomach, the empty balloon is filled with sterile saline and can be kept in place for 6-12 months, depending on the type of balloon used.



Gastric balloons are very effective at reducing appetite and improving feelings of fullness after eating. They should be regarded as effective tools, they are temporary devices that help to kick start weight loss and institute long lasting dietary and lifestyle change. Today, there are different alternatives to treat obesity in the market which include both surgical and non- surgical methods. Among which, Fluid-filled and Air-Filled Intragastric Balloons are most preferred methods of treatments due to their flexible characters.

The prevalence of overweight in high income and upper middle income countries was more than double that of low and lower middle income countries. For this reason, an increasing number of countries are owing to adopt intragastric balloon treatment to encounter the problems of obesity. Though there are various treatments available in the market to treat obesity such as bariatric surgery, gastric bypass and gastric sleeves, intragastric balloons are successfully used as the treatments costs less than surgery along with also less recovery time.

Asia Pacific will have the fastest growth, owing to a rapid increase in aging population; rise in consumer awareness; ease of treatment as a result of government policies; modernization of healthcare infrastructure; and growing medical tourism industry. This can be observed in developing nations such as China, and India in this region. Competitive landscape for each of the functions performed and form of existence of intragastric balloons market are highlighted and key market players are profiled with attributes of business overview, financials, business strategies, product portfolio and recent developments pertaining to intragastric balloons. 
1. Intragastric Balloons Market overview
2. Intragastric Balloons Market Executive summary
3. Intragastric Balloons Market Landscape
   3.1. Market share analysis
   3.2. Comparative analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Intragastric Balloons Market forces
   4.1. Market drivers
   4.2. Market constraints
   4.3. Market challenges
   4.4. Porters five force model
      4.4.1. Bargaining power of suppliers
      4.4.2. Bargaining powers of customers
      4.4.3. Threat of new entrants
      4.4.4. Rivalry among existing players
      4.4.5. Threat of substitutes 
5. Intragastric Balloons Market Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product Life Cycle
   5.5. Suppliers and Distributors
6. Intragastric Balloons Market – By Type
   6.1. Fluid Filled
   6.2. Air-Filled
7. Intragastric Balloons Market – By Geography
   7.1. Americas
      7.1.1. US
      7.1.2. Canada
      7.1.3. Mexico
      7.1.4. Brazil
      7.1.5. Rest of Americas
   7.2. Europe
      7.2.1. UK
      7.2.2. Germany
      7.2.3. France
      7.2.4. Italy
      7.2.5. Rest of Europe
   7.3. APAC
      7.3.1. China
      7.3.2. Japan
      7.3.3. India
      7.3.4. Rest of APAC
   7.4. RoW
      7.4.1. Middle East
      7.4.2. Africa
8. Intragastric Balloons Market Entropy
   8.1. New product launches
   8.2. M&A’s, collaborations, JVs and partnerships
9. Company profiles
   9.1. Apollo Endosurgery Inc.
   9.2. Obalon Therapeutics Inc.
   9.3. Allurion Technologies
   9.4. Spatz FGIA Inc.
   9.5. ReShape Medical Inc.
   9.6. Districlass Medical SA
   9.7. Silimed-Silicone E Instrumental Médico-Cirúrgico E Hospitalar Ltda
   9.8. Helioscopie
   9.9. Davol Inc. (C.R. BARD)
   9.10. Endalis
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix 
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Experts
   10.6. Disclaimer
LIST OF TABLES:

Table 1: Global Intragastric Balloon Market Revenue, By Geography, 2016-2021 ($Million)


LIST OF FIGURES:

Figure 1: Intragastric Balloon Market Revenue, By Region, 2016 and 2021 (%)
Figure 2: Intragastric Balloon Market Revenue, By Type, 2016-2021 ($Million)
Figure 3: Intragastric Balloons Market Share Analysis, By Company 2015 (%)
Figure 4: Intragastric Balloons Patents, 2012-2017 (*April)
Figure 5: Intragastric Balloons Patents Share, By Countries, 2012-2017 (%)
Figure 6: Intragastric Balloons Patents, By Applicant, 2012-2017 (*April)
Figure 7: Intragastric Balloons Market –Porter’s Five Forces
Figure 8: Intragastric balloons Treatment – Value Chain Analysis
Figure 9: Figure: Intragastric balloons Treatment Market Life Cycle, 2016-2021
Figure 10: Intragastric balloons Procedure Cost, 2016-2021 ($)
Figure 11: Intragastric Balloons Market Revenue Share, By Type, 2016 (%)
Figure 12: Fluid-Filled Intragastric: Intragastric Balloons Market Revenue 2016-2021 ($Million)
Figure 13: Air-Filled Intragastric Balloons: Intragastric Balloons Market Revenue 2016-2021 ($Million)
Figure 14: U.S.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 15: U.S.: GDP – Composition of 2015, By Sector of Origin
Figure 16: U.S.: Export and Import Value, 2012-2015 ($Trillion)
Figure 17: United States: Adult Obesity Rate, By State, 2015 (%)
Figure 18: U.S.: Intragastric Balloon Market Revenue, By Type, 2016-2021 ($ Million)
Figure 19: U.S.: Prevalence of obesity among adults aged 20 and over
Figure 20: U.S.: Trends in obesity prevalence among youth aged 2–19 years, 1999-2015, (%)
Figure 21: Canada: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 22: Canada: GDP – Composition of 2015, By Sector of Origin
Figure 23: Canada: Export and Import Value, 2012-2015 ($Billion)
Figure 24: Canada: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 25: Canada: BMI, Overweight or Obese, By Gender, 2011-2014 (Number)
Figure 26: Canada: BMI, Overweight or Obese, By Gender, 2011-2014 (%)
Figure 27: Mexico: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 28: Mexico: GDP – Composition of 2015, By Sector of Origin
Figure 29: Mexico: Export and Import Value, 2012-2015 ($Billion)
Figure 30: Mexico: Obesity Rate, 2015 (%)
Figure 31: Mexico: Per Capita Healthcare Expenditure ($)
Figure 32: Mexico: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 33: Argentina: GDP and Population, 2012-2015 ($Billion, Million)
Figure 34: Argentina: GDP – Composition of 2015, By Sector of Origin
Figure 35: Argentina: Export and Import Value, 2012-2015 ($Billion)
Figure 36: Argentina: Prevalence of Diabetes and Related Risk Factors (2015) 
Figure 37: Argentina: Per Capita Healthcare Expenditure ($)
Figure 38: Argentina: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 39: Rest of Americas: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 40: Asia Prevalence and Number of People with Diabetes (Adults 18+ Years), 1980 & 2014
Figure 41: Asia Prevalence of Being Overweight (BMI 25+) In Adults Over 18 Years, 2014, By Sex
Figure 42: APAC: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 43: APAC: Intragastric Balloons Market Revenue from Type, 2016-2021 ($Million)
Figure 44: China: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 45: China: GDP – Composition of 2015, By Sector of Origin
Figure 46: China: Export and Import Value, 2012-2015 ($Billion)
Figure 47: China: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 48: India: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 49: India: GDP – Composition of 2015, By Sector of Origin
Figure 50: India: Export and Import Value, 2012-2015 ($Billion)
Figure 51: India: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 52: Australia: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 53: Australia: GDP – Composition of 2015, By Sector of Origin
Figure 54: Australia: Export and Import Value, 2012-2015 ($Billion)
Figure 55: Australian Overweight by Time Period (%)
Figure 56: Australian Overweight/obese by state/territory, (%), 2012 
Figure 57: Australia: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 58: Malaysia: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 59: Rest of APAC: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 60: Europe: Intragastric Balloon Market Revenue, 2016-2021 ($ Million)
Figure 61: Europe: Intragastric Balloon Market Revenue, By Type, 2016-2021 ($ Million)
Figure 62: Germany: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 63: Germany: GDP – Composition of 2015, By Sector of Origin
Figure 64: Germany: Export and Import Value, 2012-2015 ($Billion)
Figure 65: Germany: Intragastric Balloon Market Revenue, By Type, 2016-2021 ($ Million)
Figure 66: Europe: Obesity in OECD Countries, 2015%)
Figure 67: France: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 68: France: GDP – Composition of 2015, By Sector of Origin
Figure 69: France: Export and Import Value, 2012-2015 ($Billion)
Figure 70: France: Intragastric Balloon Market Revenue, By Type, 2016-2021 ($Million)
Figure 71: Italy: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 72: Italy: GDP – Composition of 2015, By Sector of Origin
Figure 73: Italy: Export and Import Value, 2012-2015 ($Billion)
Figure 74: Italy: Per Capita Healthcare Expenditure, 2005-2014 ($)
Figure 75: Italy: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 76: U.K.: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 77: U.K.: GDP – Composition of 2015, By Sector of Origin
Figure 78: U.K.: Export and Import Value, 2012-2015 ($Billion)
Figure 79: U.K.: Per Capita Healthcare Expenditure, 2005-2014 ($)
Figure 80: U.K.: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 81: Obesity Drugs Prescribed per 1000 Population, UK Countries, 2008-2014 
Figure 82: Spain: GDP and Population, 2012-2015 ($Trillion, Million)
Figure 83: Spain: GDP – Composition of 2015, By Sector of Origin
Figure 84: Spain: Export and Import Value, 2012-2015 ($Billion)
Figure 85: Spain: Per Capita Healthcare Expenditure, 2005-2014 ($)
Figure 86: Spain.: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 87: Rest of Europe: Intragastric Balloons Market Revenue, 2016-2021 ($ Million)
Figure 88: RoW: Intragastric Balloons Market Revenue from Type, 2016-2021 ($Million)
Figure 89: Middle East: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 90: Africa: Intragastric Balloons Market Revenue, 2016-2021 ($Million)
Figure 91: Apollo Endosurgery, Inc., Net revenue, By Years, 2015-2016 (‘000$)
Figure 92: Apollo Endosurgery, Inc., Net Sales Share, By Business segments, 2016 (%)
Figure 93: Apollo Endosurgery, Inc., Net Sales Share, By Geography, 2016 (%)
Figure 94: Obalon Therapeutics, Inc., Net revenue, By Years, 2015-2016 (‘000$)
Figure 95: C.R. Bard, Net Sales, By Years, 2013-2016 ($Billion)
Figure 96: C.R. Bard, Net Sales Share, By Business segments, 2016 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll